EntryPoint Capital’s Usana Health Sciences USNA Stock Holding History

EntryPoint Capital’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,565	Closed	-$116K	–	1157
2024 Q2	$116K	Buy	+2,565	New	+$118K	0.17%	249

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

EntryPoint Capital's USNA Position: Q3 2024 in Review

EntryPoint Capital sold out of Usana Health Sciences (USNA) in Q3 2024, closing a stake of 2,565 shares — an estimated $116K sold.

EntryPoint Capital first reported a position in USNA in Q2 2024 and held it in 1 quarter. The position peaked at $116K in Q2 2024. 147 funds tracked by Wall St. Rank hold USNA as of Q3 2024.

EntryPoint Capital reported no remaining Usana Health Sciences position as of Q3 2024 after selling out during the quarter.
EntryPoint Capital sold 2,565 Usana Health Sciences shares in Q3 2024, an estimated $116K.
EntryPoint Capital first reported a position in Usana Health Sciences in Q2 2024 and held it in 1 quarter.
EntryPoint Capital's Usana Health Sciences position peaked at $116K in Q2 2024.
147 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2024.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.